Skip to main content
Neurologia medico-chirurgica logoLink to Neurologia medico-chirurgica
. 2024 Aug 28;64(10):353–359. doi: 10.2176/jns-nmc.2024-0069

Coil Embolization for Cerebral Aneurysm Using Low Pulse Rate Fluoroscopy

Takeshi SHIMIZU 1, Shingo TOYOTA 1, Tomoaki MURAKAMI 1, Maki KOBAYASHI 1, Haruhiko KISHIMA 2
PMCID: PMC11538802  PMID: 39198154

Abstract

Although coil embolization is commonly perceived as a minimally invasive procedure, the associated radiation exposure cannot be disregarded. To date, no specific study has investigated radiation exposure during coil embolization. This study aimed to investigate the potential of lowering the pulse rate to decrease radiation exposure during coil embolization while maintaining patient safety. Radiation data and clinical features of 70 patients who underwent coil embolization between 2015 and 2020 were retrospectively analyzed. Since July 2017, the pulse rate was regulated from 7.5 to 4 frames per second (f/s). Statistical analyses were performed to examine the correlation between pulse rate and radiation exposure. Out of the 70 procedures, 30 were performed at the standard pulse rate (7.5 f/s), and 40 were performed at the lower pulse rate (4 f/s). In the lower-pulse-rate group, the absorbed dose to the patient (AK) was 2580.7 (±217) mGy, whereas in the standard-pulse-rate group, it was 4760 (±411.1). Both the dose-area product (DAP) and AK were substantially reduced in the low pulse rate group (p = 0.000002). There was a significant correlation between DAP and AK and pulse rate (p = 0.004, p = 0.0017, respectively). Moreover, there was no significant correlation between pulse rate and perioperative complications. Our findings suggest that using a lower pulse rate (4 f/s) can effectively reduce radiation exposure during coil embolization for cerebral aneurysms while ensuring patient safety.

Keywords: radiation exposure, cerebral aneurysms, coil embolization, interventional radiology

Introduction

Recent years have seen an increased demand for endovascular treatments for cerebral aneurysms. Although the physical burden of coil embolization is considered light, the associated radiation exposure should be considered.1-4) Radiation dose to patients should be kept “as low as reasonably achievable” (ALARA principle) and is one of the easiest ways to reduce the pulse rate, which can be adjusted by the surgeon without interrupting workflow.5) The optimal pulse rate for endovascular treatments remains controversial, and in the field of cardiology, there have been reports comparing 7.5 frame per second (f/s) and 4 f/s.6) However, in the field of neurosurgery, endovascular treatments are often performed at the default setting of 7.5 f/s without a thorough examination of how low the pulse rate can be set. Therefore, we have previously reported that this adjustment during carotid stenting significantly lowers radiation dosage while maintaining patient safety.7) Despite these findings, no studies have specifically focused on radiation exposure during coil embolization for cerebral aneurysms. Therefore, this study aimed to determine if lowering the pulse rate reduced radiation exposure during coil embolization while maintaining patient safety.

Materials and Methods

Patients

This historical control study involved acquisition of radiation measurements and clinical data from 70 consecutive patients who underwent coil embolization for cerebral aneurysms between November 2015 and August 2020. Beginning in July 2017, we changed the pulse rate from 7.5 to 4 f/s; all pulse rates were intraoperatively maintained. This investigation was conducted in compliance with our institutional review board's guidelines (approval no. 191295). Written consent for patient information and images to be published was obtained from all the participants.

Treatment

Several neurosurgeons evaluated all cerebral aneurysms requiring treatment to determine whether clipping or coil embolization was the preferred treatment modality. Patients with unruptured aneurysms received 2 weeks of dual antiplatelet therapy before surgery. All patients with ruptured aneurysms received intraoperative heparin. After general anesthesia, a 9 Fr-long sheath was inserted into the groin, and then an 8 Fr FUBUKI (Asahi Intec Corporation, Aichi, Japan) was placed into the internal carotid artery. If the simple technique was unable to be completed, embolization using a balloon (Scepter XC, Microvention, Aliso Viejo, CA, USA) or stent (Neuroform Atlas, Stryker, Fremont, California, USA) was performed. Postoperative MRI images were obtained within 48 h, and cerebral angiography was performed within 1 week.

Radiation exposure

All endovascular procedures were conducted using a floor-mounted C-arm (Siemens Artis-Zee BA Twin PURE). Data were collected from a summary sheet automatically generated by the Siemens software. The collected data were the total fluoroscopic time (FT), dose area product (DAP), and total air kerma (AK). Of note, FT-as reported in this study-was determined by adding the FTs measured from the front and lateral views. In addition, DAP was measured by a DAP meter attached to the collimator (DIAMENTOR K2S Type), while AK was calculated automatically by the Siemens software based on the DAP value assuming a focus-to-subject distance of 60 cm.

Clinical outcomes

To determine the safety of coil embolization under low pulse rate fluoroscopy, we collected clinical data on perioperative complications, such as the rate of complete occlusion achieved, 90-day postoperative morbidity, the incidence of procedure-associated intraoperative perforations, symptomatic infarctions, and hemorrhage. Additional data such as the number of coils used during procedures, the coil deviation rate, and rate of retreatment within 1 year were collected. We collected neurological examinations, postoperative MRI scans, and angiography reports. The total procedural duration was obtained from the medical records. Neurological signs consistent with the imaging findings were classified as “symptomatic infarction.”

Statistics

We evaluated between-group differences in radiation exposure-as measured by DAP and AK-FT, and total procedure time using pulse rates of 4 f/s and 7.5 f/s. Furthermore, Student's t-test was used to evaluate potential between-group differences in age, maximum aneurysm diameter, dome/neck ratio, and height/neck ratio.

The chi-squared test was used to evaluate the correlation between pulse rate and categorical variables such as laterality of approach, preoperative-modified Rankin Scale (mRS) score, rate of subarachnoid hemorrhage (SAH), World Federation of Neurological Surgeons grade, sex, rate of stent assistance, rate of balloon assistance, aneurysm location, and concomitant conditions such as heart disease, diabetes mellitus, hypertension (HT), and dyslipidemia (DL).

Using multiple regression, we applied a stepwise algorithm to select significant predictive predictors of DAP and AK (among pulse rate, FT, and the other variables mentioned above). A similar procedure was used to assess the combination of significant predictors of FT.

The chi-squared test was used to evaluate the correlation between pulse rate and perioperative problems, such as the complete occlusion success rate, 90-day postoperative morbidity, the incidence of symptomatic perioperative infarctions, incidence of hemorrhage, coil deviation rate, and rate of retreatment within 1 year.

All statistical analyses were performed using the Statistical Package for the Social Sciences, version 22.0 (SPSS Inc., Armonk, NY). Two-tailed p-values < 0.05 were considered statistically significant.

Results

Table 1 shows patient and procedural characteristics. Forty and 30 patients underwent coil embolization using a pulse rate of 4 f/s and 7.5 f/s, respectively.

Table 1.

Characteristics of patients in each group

Characteristics 4 f/s (N = 40) 7.5 f/s (N = 30) p-value
Age, mean (SD) 67.2 (2.4) 68.7 (2.6) 0.317
Male, n (%) 11 (27.5) 11 (36.7) 0.414
Preoperative mRS, median (range) 0 (0-4) 0 (0-4) 0.347
SAH, n (%) 16 (40.0) 16 (53.3) 0.335
WFNS grade, median (range) 4 (1-5) 5 (1-5) 0.780
Left approach, n (%) 24 (60.0) 13 (43.3) 0.810
Retreatment case, n (%) 5 (12.5) 2 (6.7) 0.690
Max diameter (mm) 6.8 (1.3) 6.3 (0.5) 0.277
Dome/neck ratio 2.1 (0.1) 2.3 (0.2) 0.132
Height/neck ratio 1.8 (0.1) 2.3 (0.2) 0.009
Stent assist, n (%) 16 (40.0) 3 (10.0) 0.027
Balloon assist, n (%) 6 (15.0) 6 (20.0) 0.834
Location of aneurysm 0.599
Internal carotid artery, n (%) 19 (47.5) 13 (43.3)
Anterior cerebral artery, n (%) 11 (27.5) 8 (26.7)
Basilar artery, n (%) 5 (12.5) 7 (23.3)
Vertebral artery, n (%) 3 (7.5) 2 (6.7)
Middle cerebral artery, n (%) 2 (5.0) 0 (0)
Heart disease, n (%) 5 (12.5) 4 (13.3) 0.918
Diabetes mellitus, n (%) 6 (15.0) 5 (16.7) 0.850
Hypertension, n (%) 24 (60.0) 12 (40.0) 0.098
Dyslipidemia, n (%) 16 (40.0) 8 (26.7) 0.245
Other medical history, n (%) 19 (47.5) 14 (46.7) 0.945

SAH, subarachnoid hemorrhage; WFNS, World Federation of Neurosurgical Societies

Factors affecting radiation exposure

In the 4 f/s group, the mean DAP (±standard error; SE) was 15,965 (±1,046) μGym2, and the mean AK was 2580.7 (±217) mGy. In the 7.5 f/s group, the mean DAP (±SE) was 23,572 (±2,136) μGym2, and the mean AK was 4,760 (±411.1) mGy. Pulse rates of 4 and 7.5 f/s produced significant differences in DAP (p = 0.00017) and AK (p = 0.000002; Fig. 1). On multivariate analysis, pulse rate, FT, and SAH were significantly correlated with DAP; in contrast, only pulse rate was significantly correlated with AK (p = 0.004, p = 0.029, p = 0.019, p = 0.017, respectively). There were no significant correlations between DAP, AK, and the other variables (Table 2).

Fig. 1.

Fig. 1

Comparison of the mean (±standard error; SE) of DAP and AK between the two group. In the 4 f/s group, DAP was 15,965 (±1,046) μGym2 and AK was 2580.7 (±217) mGy. In the 7.5 f/s group, DAP was 23,572 (±2,136) μGym2 and AK was 4,760 (±411.1) mGy. Pulse rates of 4 and 7.5 f/s produced significant differences in DAP (p = 0.00017) and AK (p = 0.000002).

Table 2.

The results of multivariate analysis to investigate the factor affecting DAP. Pulse rate, FT, and SAH were significantly correlated with DAP

Univariate analysis Multivariate analysis 95% CI
p-value B β p-value Lower limit Upper limit
DAP variable
Pulse rate (4 f/s:low) <0.001 −6797.932 −0.341 0.004 −11311.677 −2284.187
Fluoroscopy time (min) <0.001 150.973 0.402 0.029 15.968 285.978
The number of AP imaging <0.001 −6.93 −0.007 0.981 −591.776 577.917
The number of LR imaging <0.001 408.832 0.35 0.251 −300.047 1117.711
The number of 3D imaging 0.135 103.074 0.214 0.078 −12.17 218.318
Age (years) 0.158 0.816 0.001 0.992 −166.772 168.405
Sex (male) 0.047 1042.983 0.049 0.65 −3563.225 5649.19
mRS (preoperative) 0.041 −131.509 −0.012 0.913 −2543.735 2280.717
SAH (present) 0.489 −9276.592 −0.468 0.019 −16917.223 −1635.962
WFNS grade 0.207 1520.57 0.298 0.071 −137.051 3178.191
Approach side (left) 0.214 −335.177 −0.017 0.867 −4337.176 3666.821
Retreatment case (present) 0.447 4039.321 0.123 0.353 −4645.829 12724.47
Max diameter (mm) 0.209 76.24 0.021 0.899 −1131.064 1283.544
Dome/neck ratio 0.175 2580.227 0.215 0.185 −1283.307 6443.762
Height/neck ratio 0.398 −716.061 −0.061 0.69 −4312.278 2880.157
Bleb (present) 0.32 −3357.273 −0.168 0.151 −7987.131 1272.585
Location of aneurysm 0.247 −142.26 −0.014 0.897 −228.998 2054.478
Heart disease (present) 0.01 2669.481 0.091 0.367 −3241.748 8580.71
Diabetes mellitus (present) 0.368 −171.186 −0.006 0.953 −6040.534 5698.162
Hypertension (present) 0.222 3235.623 0.164 0.196 −1729.254 8200.5
Dyslipidemia (present) 0.099 −1776.745 −0.085 0.522 −7336.375 3782.884
Other medical history (present) 0.098 3506.123 0.177 0.097 −665.209 7677.455
Stent assist (present) 0.312 −4379.206 −0.186 0.274 −12355.411 3596.998
Balloon assist (present) 0.223 −2341.723 −0.089 0.414 −8073.909 3390.463
The number of coils 0.001 −67.013 −0.035 0.849 −774.942 640.917
Operator 0.157 1384.88 0.096 0.433 −2146.699 4916.46
Complete obliteration (present) 0.208 −3501.335 −0.175 0.111 −7843.159 840.49

Factors affecting FT

We found no significant between-group differences in FT or total procedure times (p = 0.10 and p = 0.07, respectively). In the 4 f/s group, the mean (±SE) total FT was 57.4 (±3.9) min and the mean total procedure time was 210.6 (±8.4) min. In the 7.5 f/s group, the mean total FT was 65.5 (±5.2) min and the mean total procedure time was 235 (±11.9) min. Multivariate analysis revealed that the number of 3D imaging, age, retreatment case, max diameter of aneurysms, stent assist, and operator significantly correlated with FT (p = 0.036, p = 0.005, p = 0.049, p = 0.037, p = 0.015, p = 0.014, respectively; Table 3). There were no significant correlations between FT and the other variables (Table 3).

Table 3.

The results of multivariate analysis to investigate the factor affecting AK. Only pulse rate was significantly correlated with AK

Univariate analysis Multivariate analysis 95% CI
p-value B β p-value Lower limit Upper limit
AK variable
Pulse rate (4 f/s: low) <0.001 −1284.24 −0.306 0.017 −2325.79 −242.68
Fluoroscopy time (min) <0.001 22.05 0.279 0.161 −9.11 53.20
The number of AP imaging <0.001 62.37 0.287 0.356 −72.584 197.325
The number of LR imaging <0.001 3.91 0.016 0.962 −159.66 167.49
The number of 3D imaging 0.200 −6.19 −0.061 0.641 −32.78 20.41
Age (years) 0.012 26.33 0.161 0.177 −12.35 65.00
Sex (male) 0.074 221.96 0.050 0.676 −840.94 1284.85
mRS (−preoperative) 0.125 35.81 0.016 0.897 −520.82 592.43
SAH (present) 0.133 855.23 0.205 0.333 −907.86 2618.32
WFNS grade 0.210 −246.15 −0.230 0.201 −628.65 136.35
Approach side (left) 0.440 194.07 0.046 0.674 −729.40 1117.54
Retreatment case (present) 0.409 −197.02 −0.028 0.844 −2201.13 1807.10
Max diameter (mm) 0.108 4.54 0.006 0.974 −274.05 283.13
Dome/neck ratio 0.325 −10.22 −0.004 0.982 −901.74 881.30
Height/neck ratio 0.191 242.27 0.098 0.559 −587.57 1072.10
Bleb (present) 0.259 −716.05 −0.170 0.183 −1784.40 352.30
Location of aneurysm 0.292 −100.68 −0.046 0.691 −607.58 406.23
Heart disease (present) 0.062 786.01 0.127 0.251 −578.02 2150.04
Diabetes mellitus (present) 0.289 −354.60 −0.062 0.600 −1708.97 999.76
Hypertension (present) 0.278 62.39 0.015 0.913 −1083.27 1208.05
Dyslipidemia (present) 0.098 −487.36 −0.111 0.448 −1770.26 795.53
Other medical history (present) 0.234 17.45 0.004 0.971 −945.10 979.99
Stent assist (present) 0.448 132.06 0.027 0.886 −1708.47 1972.58
Balloon assist (present) 0.480 −189.82 −0.034 0.774 −1512.54 1132.89
The number of coils <0.001 43.45 0.108 0.594 −119.91 206.81
Operator 0.134 32.26 0.011 0.937 −782.66 847.18
Complete obliteration (present) 0.358 102.98 0.024 0.837 −898.91 1104.86

Perioperative complications

Overall procedural complications occurred in 4 of 70 patients (5.71%). There were no significant between-group differences for any clinical outcome, including perioperative complication rates, for pulse rates of 4 and 7.5 f/s (Table 4). There were no procedural complications leading to death.

Table 4.

Comparison of perioperative complications between the two groups using a pulse rate of 4 f/s and 7.5 f/s. There was no significant difference in the perioperative complication rates between the two groups

Clinical outcome 4 f/s (N = 40) 7.5 f/s (N = 30) p-value
Complete occlusion, n (%) 25 (62.5) 19 (63.3) 0.484
90-day morbidity, n (%) 1 (2.5) 2 (6.6) 0.394
Intraoperative perforation, n (%) 0 (0) 0 (0) -
Perioperative infarction, n (%) 2 (5.0) 2 (6.6) 0.766
The number of coils, mean (SD) 7.9 (0.9) 8.5 (1.1) 0.111
Coil deviation, n (%) 1 (2.5) 2 (6.6) 0.394
Retreatment within 1 year, n (%) 1 (2.5) 2 (6.6) 0.394

Discussion

With the recent development of devices, coiling is an increasingly popular treatment for cerebral aneurysms. However, at the same time, there is a growing concern over radiation exposure associated with endovascular treatments. As if to reflect the heightened concern about radiation exposure, recent instruments have been equipped with digital zoom functions to avoid increasing the magnification rate and low-dose high-equality imaging technology. Although this radiation exposure is multifactorial, the operator can adjust the fluoroscopic pulse rate.7) To our knowledge, this study is the first to examine the clinical effects of a 4 f/s pulse rate on radiation exposure and patient safety during coil embolization. Our results suggest that using 4 f/s pulse rate during the entire coil embolization procedure can significantly reduce radiation exposure while maintaining patient safety.

The deleterious effects of radiation exposure are deterministic and stochastic. Deterministic effects have a threshold dose and are characterized by the dose-related increase in severity and can be evaluated by AK.8-12) Stochastic effects have no threshold dose and linearly correlate with the amount of exposure and are evaluated using DAP.4,8,12) We were able to reduce AK effects by 54.2% in patients undergoing coil embolization by comparing pulse rates of 4 f/s and 7.5 f/s. Focusing on the average AK value, reducing the pulse rate to 4 f/s allowed us to stay below 3 Gy, which is the threshold of the deterministic effects such as transient erythema and hair loss. Since 5 Gy is the threshold for more severe skin symptoms, it can be considered useful in avoiding these deterministic effects as well. DAP effects were also reduced by 32.3% using 4 f/s. Reducing DAP directly correlates with lowering the risk of stochastic effects such as cancer and genetic abnormalities, depending on the degree of reduction. Thus, use of a low pulse rate (4 f/s) significantly reduced the risk of both deterministic and stochastic effects following coil embolization.

A recent report examined the safety of the “ultralow” pulse rate of 4 f/s during cardiovascular treatments.13) In the previous study, we report the safety of carotid artery stenting using 4 f/s.7) Similarly, we set 4 f/s as a threshold rate to ensure visibility for the coil embolization procedure (Supplement.1). This change did not produce additional complications or prolong the FT. Compared to large scale clinical studies, the procedural complication rate was comparable: Henkes et al. found a thromboembolic complication rate of 4.7% in 1,034 patients.14) Ross et al. reported that the rate of thromboembolic stroke was 6% in a series of 118 patients.15) Rooij reported that the rate of thromboembolic complications was 4.7% in 681 consecutive patients.16) In this study, thromboembolic findings were seen in 5.0% in 40 patients using 4 f/s. In addition, there was no mortality. It seems that reducing the pulse rate to 4 f/s did not significantly affect visibility, although this change did slightly decrease the “smoothness” of the device's motion. The statistical analysis results were also consistent with our clinical experience and support the validity of our results.

First, longer FTs associated with increasing age may reflect the impact of arterial stiffness on device operability. Second, naturally, larger masses likely require more procedures and longer FT. Moreover, using stents reduces the number of rewinding coils used for embolization, thus reducing FT.

This study had some limitations. First, several factors related to radiation exposure are difficult to quantify. For example, how to use fluoroscopy and how to maintain the distance between the patient and the flat panel detector depend on the operator. This study used data generated by multiple operators for the multivariate analyses; however, this may be insufficient for evaluation. Second, selection bias is likely present as this was a single center study, and clipping was the preferred treatment for some patients, especially in cases of wide-neck aneurysms. Therefore, further studies are needed to determine treatment outcomes in patients at higher risk during coiling procedures. Third, while all procedures were performed by specialists certified by the Society for Neuroendovascular Therapy under the supervision of the corresponding author, operator-specific factors-including skill-could affect treatment outcomes, complications, FT, or procedure time. This limitation is particularly relevant to the 4 f/s procedures performed in the latter half of this historical control study. Fourth, in this facility, all endovascular treatments in the latter half were uniformly conducted at 4 f/s, so all operators had adapted to this imaging speed. However, operators who were accustomed to treating at 7.5 f/s might feel a loss of smoothness when handling devices at 4 f/s at the same speed, potentially requiring a period to adjust. Finally, flow diverters, which are widely used, will likely require future validation because the technique considerably differs from that of embolization.

Conflicts of Interest Disclosure

The authors received no financial support for the research, authorship, and/or publication of this article.

Supplementary Material

Supplementary Table 1

Acknowledgments

T.S. and S.T. conceptualized and designed the study. All authors collected the data. T.S. analyzed the data. T.S. wrote the manuscript. S.T. and H.K. critically revised the manuscript. This work was supported by The Grant-in-aid for Community Health and Medical Care from the Osaka University Medical School Alumni.

References

  • 1). Rehani MM, Ortiz-Lopez P: Radiation effects in fluoroscopically guided cardiac interventions--keeping them under control. Int J Cardiol 109: 147-151, 2006 [DOI] [PubMed] [Google Scholar]
  • 2). Elmaraezy A, Ebraheem Morra M, Tarek Mohammed A, et al. : Risk of cataract among interventional cardiologists and catheterization lab staff: A systematic review and meta-analysis. Catheter Cardiovasc Interv 90: 1-9, 2017 [DOI] [PubMed] [Google Scholar]
  • 3). Partridge J: Radiation in the cardiac catheter laboratory. Heart 91: 1615-1620, 2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4). Wassef AW, Hiebert B, Ravandi A, et al. : Radiation dose reduction in the cardiac catheterization laboratory utilizing a novel protocol. JACC Cardiovasc Interv 7: 550-557, 2014 [DOI] [PubMed] [Google Scholar]
  • 5). Crowhurst J, Whitby M: Lowering fluoroscopy pulse rates to reduce radiation dose during cardiac procedures. J Med Radiat Sci 65: 247-249, 2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6). Wali AR, Pathuri S, Brandel MG, et al. : Reducing frame rate and pulse rate for routine diagnostic cerebral angiography: ALARA principles in practice. J Cerebrovasc Endovasc Neurosurg 26: 46-50, 2024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7). Shimizu T, Toyota S, Nakagawa K, et al. : Reduction of radiation exposure using low pulse rate fluoroscopy during neuroendovascular surgery. Interv Neuroradiol 27: 314-320, 2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8). Hirshfeld JW Jr., Balter S, Brinker JA, et al. : ACCF/AHA/HRS/SCAI clinical competence statement on physician knowledge to optimize patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol 44: 2259-2282, 2004 [DOI] [PubMed] [Google Scholar]
  • 9). Koenig TR, Mettler FA, Wagner LK: Skin injuries from fluoroscopically guided procedures: part 2. Review of 73 cases and recommendations for minimizing dose delivered to patient. AJR Am J Roentgenol 177: 13-20, 2001 [DOI] [PubMed] [Google Scholar]
  • 10). Christopoulos G, Papayannis AC, Alomar M, et al. : Determinants of operator and patient radiation exposure during cardiac catheterization: Insights from the RadiCure (RADIation reduction during cardiac catheterization using real-timE monitoring) trial. Catheter Cardiovasc Interv 88: 1046-1055, 2016 [DOI] [PubMed] [Google Scholar]
  • 11). Picano E, Vano E: The radiation issue in cardiology: the time for action is now. Cardiovasc Ultrasound 9: 35, 2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12). Gutierrez-Barrios A, Camacho-Galan H, Medina-Camacho F, et al. : Effective reduction of radiation exposure during cardiac catheterization. Tex Heart Inst J 46: 167-171, 2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13). Badawy MK, Scott M, Farouque O, et al. : Feasibility of using ultra-low pulse rate fluoroscopy during routine diagnostic coronary angiography. J Med Radiat Sci 65: 252-258, 2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14). Henkes H, Fischer S, Weber W, et al. : Endovascular coil occlusion of 1811 intracranial aneurysms: early angiographic and clinical results. Neurosurgery 54: 268-280; discussion 280-285, 2004 [DOI] [PubMed] [Google Scholar]
  • 15). Ross IB, Dhillon GS: Complications of endovascular treatment of cerebral aneurysms. Surg Neurol 64: 12-18; discussion 18-19, 2005 [DOI] [PubMed] [Google Scholar]
  • 16). van Rooij WJ, Sluzewski M, Beute GN, Nijssen PC: Procedural complications of coiling of ruptured intracranial aneurysms: incidence and risk factors in a consecutive series of 681 patients. AJNR Am J Neuroradiol 27: 1498-1501, 2006 [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Table 1

Articles from Neurologia medico-chirurgica are provided here courtesy of Japan Neurosurgical Society

RESOURCES